Hemp-Derived THC Market Faces Potential Federal Restrictions

Why it matters locally: Potential federal restrictions on hemp-derived THC products could impact agricultural businesses and retailers in Arkansas that have diversified into this market following the 2018 Farm Bill.

WASHINGTON D.C. — The American market for impairing hemp products, valued at approximately $28 billion, confronts potential federal restrictions after a recent congressional vote. Lawmakers moved to close what they describe as a loophole in federal law, which has enabled the industry's growth. The 2018 Farm Bill legalized hemp nationally, defining it as cannabis with less than 0.3% Delta-9 tetrahydrocannabinol (THC) by dry weight. This legislation differentiated hemp from marijuana. Following the bill's passage, the hemp industry began producing and selling products containing other intoxicating cannabinoids, such as Delta-8 THC and Delta-10 THC, derived from legally compliant hemp. These cannabinoids are structurally similar to Delta-9 THC, the primary psychoactive compound in marijuana. Manufacturers extract these compounds from hemp biomass, chemically converting non-intoxicating cannabinoids like cannabidiol (CBD) into psychoactive forms. Regulators in several states have expressed concerns about the unregulated nature of these products. These concerns often center on product purity, potency, and labeling accuracy, as the industry operates largely outside the regulatory frameworks applied to marijuana. Advocates for the hemp-derived THC industry argue that a ban would harm thousands of businesses and eliminate jobs across the country. They also contend that these products offer a less potent alternative to traditional marijuana, providing consumers with a wider range of options. Opponents of the current market structure cite public health and safety concerns. They argue that the products are readily available to individuals under 21, the legal age for marijuana consumption in states where it is permitted. They also point to the lack of federal oversight regarding manufacturing processes and product testing. Industry participants now await further legislative developments that could redefine the legality and future of hemp-derived intoxicating products.